XTNT— Xtant Medical Holdings, Inc.

Health Care$62M mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
Total Revenue	$133.9M+14.2%	$117.3M+28.4%	$91.3M+57.5%	$58.0M
Cost of Sales	$49.7M+1.2%	$49.1M+36.9%	$35.8M+38.7%	$25.8M
Gross Profit	$84.3M+23.5%	$68.2M+23.0%	$55.5M+72.6%	$32.1M
General and administrative	$29.4M+2.4%	$28.7M+11.0%	$25.9M+67.2%	$15.5M
Sales and marketing	$45.5M-7.5%	$49.2M+28.0%	$38.4M+70.7%	$22.5M
Research and development	$2.1M-11.9%	$2.4M+78.5%	$1.3M+46.0%	$915K
Total Operating Expenses	$77.0M-4.1%	$80.3M+22.3%	$65.6M+68.7%	$38.9M
Income (Loss) from Operations	$7.3M+160.3%	-$12.1M-18.9%	-$10.2M-50.4%	-$6.8M
Interest expense	-$3.7M+11.8%	-$4.2M-41.6%	-$2.9M-73.6%	-$1.7M
Interest income	$94K-36.9%	$149K+0.0%	$149K+380.6%	$31K
Unrealized foreign currency translation (loss) gain	-$60K-1300.0%	$5K-98.1%	$265K	—
Gain on divestiture	$3.3M	—	—	—
Other income (expense)	$73K+321.2%	-$33K	—	—
Total Other (Expense) Income	-$283K+93.2%	-$4.2M-145.9%	$9.1M+649.1%	-$1.7M
Net Income (Loss) from Operations Before Provision for Income Taxes	$7.0M+143.1%	-$16.3M-1468.2%	-$1.0M+87.7%	-$8.4M
Provision for Income Taxes Current and Deferred	-$2.0M-984.5%	-$187K-111.0%	$1.7M+2559.4%	-$69K
Net Income (Loss)	$5.0M+130.2%	-$16.4M-2592.3%	$660K+107.8%	-$8.5M
Basic	$40+133.3%	-$120-1300.0%	$10+111.1%	-$90
Dilutive	$30+125.0%	-$120-1300.0%	$10+111.1%	-$90
Basic	$139.53B+4.4%	$133.67B+12.2%	$119.09B+26.6%	$94.09B
Dilutive	$150.04B+12.3%	$133.67B+5.4%	$126.79B+34.8%	$94.09B
Product [Member]
License [Member]

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 12 more years of annual history and full quarterly detail on Pro.

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.